Nanoformulated antimicrobial agents for central nervous system infections
MetadataShow full item record
© 2017 American Scientific Publishers All rights reserved. Meningitis and encephalitis caused by bacteria and fungi are among the top 10 lethal types of infectious diseases. The treatment of brain infection is principally limited by the blood-brain barrier (BBB), which restricts the entry of antimicrobial agents to the desired central nervous system (CNS). To address this issue, many different nanoparticles conjugated with targeting ligands have been employed to increase CNS penetration of several antifungal drugs like amphotericin B and itraconazole. However, a wide spectrum of microorganisms have provoked the diseases, and some have developed multidrug resistance to nearly all commercially available antibiotics. Therefore, there is an urgent need to design unconventional nanostructures that possess both novel biocidal modes and brain targeting property. This review focuses on classical nanocarriers enabling brain delivery of loaded antibiotics as well as highlights recent progress in the fabrication of transactivator of transcription (TAT) peptide-containing nanoparticles to circumvent BBB and kill the pathogenic microbes in brain tissue. The later strategy, albeit imperfect, may allow nanoantibiotics to target, diagnose and treat brain infection simultaneously in an unprecedented manner.
Showing items related by title, author, creator and subject.
Characterising murine hippocampal iron homeostasis, in relation to markers of brain inflammation and metabolism, during ageingEllison, Gae ; Duong, Lelinh; Hollings, Ashley ; Howard, D.; Jackaman, Connie ; Hackett, Mark (2022)Metal ions (Fe, Cu, and Zn) are essential to a healthy brain function, with the amount, localisation, and chemical form often tightly controlled. Evidence points towards loss of metal ion homeostasis within the ageing ...
The effect of physiotherapy on the prevention and treatment of ventilator-associated pneumonia for intensive care patients with acquired brain injuryPatman, Shane Michael (2005)Background: Ventilator-associated pneumonia is a major cause of morbidity and mortality for patients in an intensive care unit. Once present, ventilator-associated pneumonia is known to increase the duration of mechanical ...
Norata, Giuseppe; Venu, V.; Callegari, E.; Paloschi, V.; Catapano, A. (2012)The reduced expression (haplodeficiency) of the main brain derived neurotrophic factor receptor, namely TrkB is associated with reduced atherosclerosis, smooth muscle cells accumulation and collagen content in the lesion. ...